- Home
- AMPG vs NXL Comparison
AMPG vs NXL Comparison
Compare AMPG & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPG
- NXL
- Stock Information
- Founded
- AMPG 2002
- NXL 2010
- Country
- AMPG United States
- NXL United States
- Employees
- AMPG N/A
- NXL N/A
- Industry
- AMPG Telecommunications Equipment
- NXL Medical Specialities
- Sector
- AMPG Telecommunications
- NXL Health Care
- Exchange
- AMPG Nasdaq
- NXL Nasdaq
- Market Cap
- AMPG 29.1M
- NXL 31.1M
- IPO Year
- AMPG N/A
- NXL 2022
- Fundamental
- Price
- AMPG $1.50
- NXL $2.01
- Analyst Decision
- AMPG Strong Buy
- NXL Strong Buy
- Analyst Count
- AMPG 1
- NXL 1
- Target Price
- AMPG $5.00
- NXL $5.00
- AVG Volume (30 Days)
- AMPG 260.9K
- NXL 110.3K
- Earning Date
- AMPG 05-27-2025
- NXL 03-14-2025
- Dividend Yield
- AMPG N/A
- NXL N/A
- EPS Growth
- AMPG N/A
- NXL N/A
- EPS
- AMPG N/A
- NXL N/A
- Revenue
- AMPG $9,508,372.00
- NXL $168,721.00
- Revenue This Year
- AMPG N/A
- NXL $79.59
- Revenue Next Year
- AMPG $58.88
- NXL $334.65
- P/E Ratio
- AMPG N/A
- NXL N/A
- Revenue Growth
- AMPG N/A
- NXL 52.35
- 52 Week Low
- AMPG $0.64
- NXL $0.53
- 52 Week High
- AMPG $6.43
- NXL $4.49
- Technical
- Relative Strength Index (RSI)
- AMPG 39.40
- NXL 40.46
- Support Level
- AMPG $1.42
- NXL $1.82
- Resistance Level
- AMPG $1.60
- NXL $2.57
- Average True Range (ATR)
- AMPG 0.14
- NXL 0.22
- MACD
- AMPG -0.00
- NXL -0.01
- Stochastic Oscillator
- AMPG 15.69
- NXL 25.33
About AMPG Amplitech Group Inc.
AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.